Streptomycin (streptomycin) powder for solution for injection 0.5 g. №1 vial

$6.00

Manufacturer: Ukraine

Purpose: Inhibits bacterial protein synthesis; treats infections caused by susceptible bacteria.

SKU: MED61469 Categories: , ,

Description

Streptomycin (streptomycin) powder for solution for injection 0.5 g. №1 vial

Ingredients:

Each vial contains 0.5 g of streptomycin.

Dosage:

The dosage should be determined by a healthcare professional based on the condition being treated. It is typically administered via intramuscular or intravenous injection.

Indications:

Streptomycin is commonly used to treat tuberculosis and other bacterial infections. It works by inhibiting protein synthesis in susceptible bacteria.

Contraindications:

Do not use streptomycin if you are allergic to it or have kidney issues. It is important to discuss any existing medical conditions with your healthcare provider before starting treatment.

Directions:

Follow the instructions provided by your healthcare provider for the correct administration of streptomycin. Do not exceed the recommended dosage.

Scientific Evidence:

Studies have shown streptomycin to be effective in the treatment of various bacterial infections, especially tuberculosis. Research published in the International Journal of Tuberculosis and Lung Disease demonstrated the efficacy of streptomycin in combination therapy for drug-resistant tuberculosis.

Additional Information:

It is important to complete the full course of streptomycin as prescribed by your healthcare provider to ensure the best possible outcome. Monitor for any side effects and report them to your doctor promptly.

Streptomycin is an antibiotic that belongs to the aminoglycoside class of medications. It works by disrupting protein synthesis in bacteria, leading to their death. This mechanism of action makes streptomycin effective against a wide range of gram-negative and some gram-positive bacteria.

Clinical trials have shown streptomycin to be particularly valuable in the treatment of multidrug-resistant tuberculosis. A study published in the Journal of the American Medical Association (JAMA) Internal Medicine found that streptomycin-based regimens were associated with higher treatment success rates compared to other drug combinations.